Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP184315.RA_m7OkLUPZctHUn4ZkEbWOjG3okYVL99_yQhMV52EY4E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP184315.RA_m7OkLUPZctHUn4ZkEbWOjG3okYVL99_yQhMV52EY4E130_assertion type Assertion NP184315.RA_m7OkLUPZctHUn4ZkEbWOjG3okYVL99_yQhMV52EY4E130_head.
- NP184315.RA_m7OkLUPZctHUn4ZkEbWOjG3okYVL99_yQhMV52EY4E130_assertion description "[Therefore, targeting PG and/or p65 NF-kappaB may be useful for treating cancers, which are dependent on autocrine or circulating PGs for their growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184315.RA_m7OkLUPZctHUn4ZkEbWOjG3okYVL99_yQhMV52EY4E130_provenance.
- NP184315.RA_m7OkLUPZctHUn4ZkEbWOjG3okYVL99_yQhMV52EY4E130_assertion evidence source_evidence_literature NP184315.RA_m7OkLUPZctHUn4ZkEbWOjG3okYVL99_yQhMV52EY4E130_provenance.
- NP184315.RA_m7OkLUPZctHUn4ZkEbWOjG3okYVL99_yQhMV52EY4E130_assertion SIO_000772 17671195 NP184315.RA_m7OkLUPZctHUn4ZkEbWOjG3okYVL99_yQhMV52EY4E130_provenance.
- NP184315.RA_m7OkLUPZctHUn4ZkEbWOjG3okYVL99_yQhMV52EY4E130_assertion wasDerivedFrom befree-20140225 NP184315.RA_m7OkLUPZctHUn4ZkEbWOjG3okYVL99_yQhMV52EY4E130_provenance.
- NP184315.RA_m7OkLUPZctHUn4ZkEbWOjG3okYVL99_yQhMV52EY4E130_assertion wasGeneratedBy ECO_0000203 NP184315.RA_m7OkLUPZctHUn4ZkEbWOjG3okYVL99_yQhMV52EY4E130_provenance.